• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
MRNA

MRNA

Moderna, Inc.

NASDAQHealthcareBiotechnologyUS

USD49.06

+3.42 (+7.49%)

Rating:C-

Company Profile

CEO

Stéphane Bancel

IPO Date

2018-12-07

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$45.30

Prev. Close

$45.64

Day Low

$45.30

Day High

$49.55

52W Low

$22.28

52W High

$59.55

Market Cap

$19.47B

Volume

6.75M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

37.6%

Avg Negative

26.2%

Avg Neutral

36.1%

News Feed

Moderna, Merck cancer combo cuts melanoma spread risk at five years

reuters.com·5/21/2026·↑ positive

US FDA to hold expert committee meeting to review Moderna's flu vaccine

reuters.com·5/21/2026·↑ positive

Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Now

247wallst.com·5/21/2026·↑ positive

Moderna, Inc. (MRNA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

seekingalpha.com·5/19/2026·↑ positive

Moderna Recognized by TIME as One of the World's Most Impactful Companies

accessnewswire.com·5/12/2026·↑ positive

Moderna, Inc. (MRNA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

seekingalpha.com·5/12/2026·↑ positive

Moderna's AI Could Get a Hantavirus Vaccine Here Faster

pymnts.com·5/12/2026·↓ negative

Hantavirus outbreak: these 3 stocks are poised to rip higher

invezz.com·5/11/2026·↓ negative

Moderna Says It's Researching a Hantavirus Vaccine. The Drugmaker's Stock Is Surging.

investopedia.com·5/11/2026·↑ positive

Here's how much Moderna's stock has rallied off renewed focus on hantavirus research

marketwatch.com·5/11/2026·↓ negative